Skip to main content

Table 3 Changes in the severity of pruritus between patients with and those without diabetes mellitus

From: Effectiveness of a treatment algorithm for hemodialysis-associated pruritus in terms of changes in medications

Patient group

2009

2013

2014

2015

2016

2017

2018

P value*

DM

n = 41

n = 65

n = 78

n = 94

n = 84

n = 98

n = 106

 

 Median Shiratori severity score for daytime pruritus [IQR]

2 [2, 3]

2[1, 2]

2 [1, 2]

1 [1, 2]

1 [1, 2]

1 [0, 2]

1 [0, 2]

< 0.001

 Median Shiratori severity score for nighttime pruritus [IQR]

2 [1, 2]

2 [1, 2]

2 [0.3, 2]

1 [0, 2]

1 [0, 1]

1 [0, 1]

1 [0, 1]

< 0.001

 Median VAS score [IQR] (mm)

51 [40, 66.5]

48 [30, 68]

34 [19.3, 56.3]

35 [11.5, 60]

22 [10.8, 42]

21 [0.3, 37.3]

23.5 [0, 50]

< 0.001

Non-DM

n = 48

n = 66

n = 86

n = 96

n = 97

n = 117

n = 118

 

 Median Shiratori severity score for daytime pruritus [IQR]

3 [1.3, 3]

2 [1, 2]

2 [1, 2]

1 [0, 2]

1 [0, 2]

1 [0, 2]

1 [0, 2]

< 0.001

 Median Shiratori severity score for nighttime pruritus [IQR]

2 [2, 3]

2 [1, 2]

2 [1, 2]

1 [0, 1]

1 [0, 1]

0 [0, 1]

0 [0, 1]

< 0.001

 Median VAS score [IQR] (mm)

54 [40.8, 74.5]

46.5 [27.8, 60]

40 [20, 61]

25 [2, 49]

20 [0, 33]

15 [0, 30]

25.5 [0, 50.8]

< 0.001

  1. *P values were calculated using the Kruskal-Wallis test